Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon May 21, 2020 12:38pm
48 Views
Post# 31056762

RE:ualcin = gobb

RE:ualcin = gobbSo realstups, you are saying people should sell.  Very interesting, first I have heard that.


realstocky wrote: same genius.  These people on this board telling  you to sell are only buying you shares,  with the partnership (riplazym) and the FDA green light, this will trade between 50$ and 100$ this year. Owners own 85% of all shares..  look at the float/market cap....


<< Previous
Bullboard Posts
Next >>